Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study

Published:2023-04 Issue:2 Volume:72 Page:286-296
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Hide Michihiro,Fukunaga Atsushi,Suzuki Takayuki,Nakamura Noriko,Kimura Mine,Sasajima Takayoshi,Kiriyama Junna,Igarashi Atsuyuki

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference27 articles.

1. The EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis and management of urticaria;Zuberbier;Allergy,2022

2. [Japanese guidelines for diagnosis and treatment of urticaria 2018];Hide;Arerugi,2018

3. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis;Fricke;Allergy,2020

4. [Analysis of the prevalence of subtype of urticaria and angioedema];Tanaka;Arerugi,2006

5. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine;Hiragun;Allergy,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

2. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

3. Disease Control and Treatment Satisfaction in Patients with Chronic Spontaneous Urticaria in Japan;Journal of Clinical Medicine;2024-05-17

4. Omalizumab;Reactions Weekly;2024-03-09

5. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients;Acta Dermato-Venereologica;2023-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3